Literature DB >> 24400219

Alpha-fetoprotein-L3: Useful or Useless for Hepatocellular Carcinoma?

M Kudo1.   

Abstract

Entities:  

Year:  2013        PMID： 24400219      PMCID： PMC3881313          DOI： 10.1159/000343847

Source DB:  PubMed          Journal:  Liver Cancer        ISSN： 1664-5553            Impact factor:   11.740


× No keyword cloud information.
  6 in total

1.  Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Seiki Kiriyama; Yasuhiro Sone; Makoto Tanikawa; Yasuhiro Hisanaga; Shusuke Kitabatake; Teiji Kuzuya; Koji Nonogaki; Junichi Shimizu; Akihiro Yamaguchi; Masatoshi Isogai; Yuji Kaneoka; Junji Washizu; Shinji Satomura
Journal:  Liver Int       Date:  2005-08       Impact factor: 5.828

2.  Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment.

Authors:  Yasushi Tamura; Masato Igarashi; Takeshi Suda; Toshifumi Wakai; Yoshio Shirai; Takeji Umemura; Eiji Tanaka; Satoru Kakizaki; Hitoshi Takagi; Yoichi Hiasa; Morikazu Onji; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2010-07       Impact factor: 3.199

3.  Comparison of carbohydrate structures of serum alpha-fetoprotein by sequential glycosidase digestion and lectin affinity electrophoresis.

Authors:  K Shimizu; H Katoh; F Yamashita; M Tanaka; K Tanikawa; K Taketa; S Satomura; S Matsuura
Journal:  Clin Chim Acta       Date:  1996-10-15       Impact factor: 3.786

4.  Clinical advantage of highly sensitive on-chip immunoassay for fucosylated fraction of alpha-fetoprotein in patients with hepatocellular carcinoma.

Authors:  Yasushi Tamura; Masato Igarashi; Hirokazu Kawai; Takeshi Suda; Shinji Satomura; Yutaka Aoyagi
Journal:  Dig Dis Sci       Date:  2010-04-21       Impact factor: 3.199

5.  Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein <20 ng/mL.

Authors:  Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Yuji Kaneoka; Atsuyuki Maeda; Futoshi Kanke; Shinji Satomura
Journal:  Cancer Sci       Date:  2011-02-28       Impact factor: 6.716

6.  Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis.

Authors:  T Kumada; S Nakano; I Takeda; S Kiriyama; Y Sone; K Hayashi; H Katoh; T Endoh; T Sassa; S Satomura
Journal:  J Hepatol       Date:  1999-01       Impact factor: 25.083
  6 in total
  6 in total

1.  Should AFP (or any biomarkers) be used for HCC surveillance?

Authors:  Hager F Ahmed Mohammed; Lewis R Roberts
Journal:  Curr Hepatol Rep       Date:  2017-04-28

2.  Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe.

Authors: 
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

Review 3.  Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan.

Authors:  Masatoshi Kudo
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

4.  Diagnostic Performance of AFP, AFP-L3, or PIVKA-II for Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Multicenter Analysis.

Authors:  Siyu Liu; Liyang Sun; Lanqing Yao; Hong Zhu; Yongkang Diao; Mingda Wang; Hao Xing; Wan Yee Lau; Mingcheng Guan; Timothy M Pawlik; Feng Shen; Min Xu; Xiangmin Tong; Tian Yang
Journal:  J Clin Med       Date:  2022-08-29       Impact factor: 4.964

5.  ASAP Score versus GALAD Score for detection of hepatitis C-related hepatocellular carcinoma: A multicenter case-control analysis.

Authors:  Si-Yu Liu; Chao Li; Li-Yang Sun; Ming-Cheng Guan; Li-Hui Gu; Dong-Xu Yin; Lan-Qing Yao; Lei Liang; Ming-Da Wang; Hao Xing; Hong Zhu; Timothy M Pawlik; Wan Yee Lau; Feng Shen; Xiang-Min Tong; Tian Yang
Journal:  Front Oncol       Date:  2022-09-30       Impact factor: 5.738

Review 6.  Novel biomarkers for the management of chronic hepatitis B.

Authors:  Takako Inoue; Yasuhito Tanaka
Journal:  Clin Mol Hepatol       Date:  2020-06-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.